GlassScriptPhysician profile
Susan E Freeberg
NPI 1932165370
$2,291.23
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $491 · 2021: $242 · 2022: $637 · 2023: $646.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $566 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $565.84 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $478.23 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $364.81 | 2020-2023 | |
| Sun Pharmaceutical Industries INC. | $347.55 | 2020-2023 | Odomzo, Blu-U, Winlevi |
| Janssen Biotech, INC. | $148.20 | 2021-2023 | Tremfya |
| Genentech USA, INC. | $135.46 | 2019-2022 | |
| Amgen INC. | $113.46 | 2020-2023 | Otezla |
| Lilly USA, LLC | $97.15 | 2022-2023 | Taltz, Olumiant |
| Regeneron Healthcare Solutions, INC. | $91.55 | 2020-2023 | Libtayo |
| E.R. Squibb & Sons, L.L.C. | $89.27 | 2023 | Sotyktu |
| Genzyme Corporation | $80.86 | 2022 | |
| Mayne Pharma Commercial LLC | $67.38 | 2020 | |
| Pfizer INC. | $57.74 | 2020-2021 | |
| Incyte Corporation | $52.25 | 2022-2023 | Opzelura |
| Ucb, INC. | $41.98 | 2020 | |
| Biofrontera INC. | $28.21 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $23.62 | 2023 | Vtama |
| Leo Pharma INC. | $18.60 | 2023 | Adbry |
| Organogenesis INC. | $15.61 | 2023 | Puraply |
| Helsinn Therapeutics (U.S.), INC. | $13.70 | 2022 | |
| Vyne Pharmaceuticals INC. | $12.84 | 2020 | |
| Dermira, INC. | $12.76 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Freeberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.